PT - JOURNAL ARTICLE AU - R. Whitehead AU - S. Greci AU - H Thomson AU - G. Armour AU - K. Angus AU - L. Martin TI - The Impact of Non-Price In-premise Marketing on Food and Beverage Purchasing and Consumer Behaviour: A Systematic Review AID - 10.1101/2021.09.13.21258115 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.13.21258115 4099 - http://medrxiv.org/content/early/2021/09/16/2021.09.13.21258115.short 4100 - http://medrxiv.org/content/early/2021/09/16/2021.09.13.21258115.full AB - In-premise marketing is commonly used to promote foods that are high in fat, sugar or salt. In order to inform development of public policy in this area, this systematic review sought to determine the quantity and quality of English-language evidence which examines the role and impact of in-premise advertising (e.g., signage, posters) and positional promotions (e.g., checkout displays) on consumer behaviour and diet-related outcomes in retail, out-of-home (i.e., cafés, restaurants, takeaways) and online purchasing environments. Sixty-two studies met inclusion criteria, of which 69% (n=42) were identified as being methodologically weak. The best-available evidence constitutes findings from four methodologically strong studies, and ten moderate studies which are not confounded by additional promotions such as price or availability. These studies predominantly found evidence that in-premise marketing is likely to be successful in influencing consumer behaviour towards targeted items, across retail and out-of-home settings. These findings provide a basis for authorities to consider acting to restrict in-premise marketing of unhealthy foods and encouraging the in-premise marketing of healthier products. This review identified gaps in the evidence available on non-sales outcomes, and on online purchase environments. These gaps, and identified methodological limitations of the extant evidence remain to be addressed by future research.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=169720 Funding StatementHT is funded by the UK Medical Research Council (MC_UU_12017-15) and the Scottish Government Chief Scientist Office (SPHSU15)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData extracted from articles included in this systematic review are presented as supplementary information.HFSS(foods) high in fat, sugar or saltPRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysesSWiMSynthesis Without Meta-analysisBMIbody mass index (kg/m2)EPHPPEffective Public Health Practice ProjectUKUnited KingdomGRADEGrading of Recommendations, Assessment, Development and Evaluation